Towards a Harmonised EU Assessment of the Added Therapeutic Value of Medicines
TThis study, produced for the ENVI Committee by Policy Department A, investigates the possibility of a harmonised EU approach concerning the assessment of the added therapeutic value (ATV) of medicinal products. It reviews the current EU legal and policy framework and looks at the state-of-play within all 28 Member States. In addition, it presents the results of an in-depth analysis on the use of ATV in six selected EU countries. The study closes with policy recommendations on how a possible European harmonisation of the ATV assessment might be taken forward within the current legal framework.
Uuring
Parlamendiväline autor
VAN WILDER Philippe (Vrije Universiteit Brussel and SMART&BI), MABILIA Valentina (Milieu Ltd.), KUIPERS CAVACO Yoline (Milieu Ltd.) and MCGUINN Jennifer (Milieu Ltd.)
Dokumendi info
Väljaande liik
Poliitikavaldkond
Märksõna
- Austria
- ELi riigid
- ETTEVÕTLUS JA KONKURENTS
- Euroopa
- GEOGRAAFIA
- hindade kinnitamine
- hindamismeetod
- hinnad
- Itaalia
- KAUBANDUS
- kulude-tulude analüüs
- kulutasuvuse analüüs
- majandusgeograafia
- müügiluba
- poliitiline geograafia
- Poola
- Prantsusmaa
- raamatupidamine
- RAHANDUS
- ravim
- ravimijärelevalve
- Rootsi
- Slovakkia
- SOTSIAALKÜSIMUSED
- sotsiaalne kaitse
- tervis
- tervisekindlustus
- tervishoiukulud
- tervishoiukulutused
- TOOTMINE, TEHNOLOOGIA JA UURIMINE
- turundus
- uurimine ja intellektuaalomand